Deep learning for preoperative prediction of the EGFR mutation and subtypes based on the MRI image of spinal metastasis from primary NSCLC

Siegel, 2020, Cancer statistics, 2020, CA A Cancer J Clin, 70, 7, 10.3322/caac.21590 Vaid, 2021, Overall survival in stage IV EGFR mutation-positive NSCLC: Comparing first-, second- and third-generation EGFR-TKIs (Review), Int. J. Oncol., 58, 171, 10.3892/ijo.2021.5168 Sun, 2021, Neoadjuvant EGFR-TKI Therapy for EGFR-Mutant NSCLC: A Systematic Review and Pooled Analysis of Five Prospective Clinical Trials, Front. Oncol., 10, 10.3389/fonc.2020.586596 Recondo, 2018, Making the first move in EGFR-driven or ALK-driven NSCLC: first-generation or next-generation TKI?, Nat. Rev. Clin. Oncol., 15, 694, 10.1038/s41571-018-0081-4 Kim, 2017, Dynamic Contrast-enhanced MR Imaging Parameters in Bone Metastases from Non-Small Cell Lung Cancer: Comparison between Lesions with and Lesions without Epidermal Growth Factor Receptor Mutation in Primary Lung Cancer, Radiology, 284, 815, 10.1148/radiol.2017162336 Sousa, 2020, Detection of rare and novel EGFR mutations in NSCLC patients: Implications for treatment-decision, Lung cancer (Amsterdam, Netherlands), 139, 35, 10.1016/j.lungcan.2019.10.030 Liu, 2020, 3D radiomics predicts EGFR mutation, exon-19 deletion and exon-21 L858R mutation in lung adenocarcinoma, Transl. Lung Cancer Res., 9, 1212, 10.21037/tlcr-20-122 Renaud, 2018, Prognostic Value of Exon 19 Versus 21 EGFR Mutations Varies According to Disease Stage in Surgically Resected Non-small Cell Lung Cancer Adenocarcinoma, Ann. Surg. Oncol., 25, 1069, 10.1245/s10434-018-6347-3 Hong, 2019, Prognostic value of EGFR 19-del and 21–L858R mutations in patients with non-small cell lung cancer, Oncol. Lett., 18, 3887 Kuchuk, 2015, The incidence and clinical impact of bone metastases in non-small cell lung cancer, Lung cancer (Amsterdam, Netherlands), 89, 197, 10.1016/j.lungcan.2015.04.007 Temel, 2010, Early palliative care for patients with metastatic non-small-cell lung cancer, New England J. Med., 363, 733, 10.1056/NEJMoa1000678 Krawczyk, 2014, The incidence of EGFR-activating mutations in bone metastases of lung adenocarcinoma, Pathol. Oncol. Res. POR, 20, 107, 10.1007/s12253-013-9667-4 Song, J., Shi, J., Dong, D., Fang, M., Zhong, W., Wang, K., Wu, N., Huang, Y., Liu, Z., Cheng, Y., Gan, Y., Zhou, Y., Zhou, P., Chen, B., Liang, C., Liu, Z., Li, W., & Tian, J. (2018). A New Approach to Predict Progression-free Survival in Stage IV EGFR-mutant NSCLC Patients with EGFR-TKI Therapy. Clinical cancer research : an official journal of the American Association for Cancer Research, 24(15), 3583–3592. https://doi.org/10.1158/1078-0432.CCR-17-2507. Kim, 2020, Diagnostic Yield of Staging Brain MRI in Patients with Newly Diagnosed Non-Small Cell Lung Cancer, Radiology, 297, 419, 10.1148/radiol.2020201194 Aerts, 2014, Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach, Nat. Commun., 5, 4006, 10.1038/ncomms5006 Avanzo, 2020, Machine and deep learning methods for radiomics, Med. Phys., 47, e185, 10.1002/mp.13678 Cao, 2022, MRI-Based Radiomics Nomogram as a Potential Biomarker to Predict the EGFR Mutations in Exon 19 and 21 Based on Thoracic Spinal Metastases in Lung Adenocarcinoma, Acad. Radiol., 29, e9, 10.1016/j.acra.2021.06.004 Jiang, 2021, Multiparametric MRI-Based Radiomics Approaches for Preoperative Prediction of EGFR Mutation Status in Spinal Bone Metastases in Patients with Lung Adenocarcinoma, J. Magn. Resonan. Imag. JMRI, 54, 497, 10.1002/jmri.27579 Zheng, 2020, Deep learning radiomics can predict axillary lymph node status in early-stage breast cancer, Nat. Commun., 11, 1236, 10.1038/s41467-020-15027-z Levine, 2019, Rise of the Machines: Advances in Deep Learning for Cancer Diagnosis, Trends in cancer, 5, 157, 10.1016/j.trecan.2019.02.002 Chaudhary, K., Poirion, O. B., Lu, L., & Garmire, L. X. (2018). Deep Learning-Based Multi-Omics Integration Robustly Predicts Survival in Liver Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 24(6), 1248–1259. https://doi.org/10.1158/1078-0432.CCR-17-0853. Pan, 2019, Deep Learning Reveals Cancer Metastasis and Therapeutic Antibody Targeting in the Entire Body, Cell, 179, 1661, 10.1016/j.cell.2019.11.013 Wang, 2019, Predicting EGFR mutation status in lung adenocarcinoma on computed tomography image using deep learning, Eur. Resp. J., 53, 1800986, 10.1183/13993003.00986-2018 Silva, 2021, Egfr assessment in lung cancer ct images: analysis of local and holistic regions of interest using deep unsupervised transfer learning, IEEE Access, 9, 58667, 10.1109/ACCESS.2021.3070701 Yin, 2021, Prediction of EGFR Mutation Status Based on 18F-FDG PET/CT Imaging Using Deep Learning-Based Model in Lung Adenocarcinoma, Front. Oncol., 11 Jiang, 2021, Multiparametric MRI-Based Radiomics Approaches for Preoperative Prediction of EGFR Mutation Status in Spinal Bone Metastases in Patients with Lung Adenocarcinoma, J. Magn. Reson. Imaging, 54, 497, 10.1002/jmri.27579 Fan, 2021, Subregional radiomics analysis for the detection of the EGFR mutation on thoracic spinal metastases from lung cancer, Phys. Med. Biol., 66, 215008, 10.1088/1361-6560/ac2ea7 Woo, Sanghyun & Park, JongChan & Lee, Joon-Young & Kweon, Inso. (2018). CBAM: Convolutional Block Attention Module. Tan, Mingxing & Le, Quoc. (2021). EfficientNetV2: Smaller Models and Faster Training. Prasanna, 2021, Automated Epileptic Seizure Detection in Pediatric Subjects of CHB-MIT EEG Database-A Survey, J. Personalized Med., 11, 1028, 10.3390/jpm11101028 Senthilkumar, 2021, Incorporating artificial fish swarm in ensemble classification framework for recurrence prediction of cervical cancer, IEEE Access, 9, 83876, 10.1109/ACCESS.2021.3087022 Hussein, 2022, Fully-automatic identification of gynaecological abnormality using a new adaptive frequency filter and histogram of oriented gradients (HOG), Expert Systems, 39, 10.1111/exsy.12789 Benameur, 2021, Parametric methods for the regional assessment of cardiac wall motion abnormalities: comparison study, Cmc -Tech Science Press-, 69, 1233 Husham, 2020, Comparative Analysis between Active Contour and Otsu Thresholding Segmentation Algorithms in Segmenting Brain Tumor Magnetic Resonance Imaging, J. Inform. Technol. Managem., Special Issue, 48 Soni, M., Gomathi, S., Kumar, P., Churi, P. P., Mohammed, M. A., & Salman, A. O. (2022). Hybridizing Convolutional Neural Network for Classification of Lung Diseases. International J. Swarm Intell. Res. (IJSIR), 13(2), 1-15. http://doi.org/10.4018/IJSIR.287544. Liu, 2016, Radiomic Features Are Associated With EGFR Mutation Status in Lung Adenocarcinomas, Clin. Lung Cancer, 17, 441, 10.1016/j.cllc.2016.02.001 Gevaert, 2017, Predictive radiogenomics modeling of EGFR mutation status in lung cancer, Sci. Rep., 7, 41674, 10.1038/srep41674 Yuan, 2017, Lung adenocarcinoma: Assessment of epidermal growth factor receptor mutation status based on extended models of diffusion-weighted image, J. Magn. Reson. Imag. JMRI, 46, 281, 10.1002/jmri.25572 Zhang, 2018, Quantitative Biomarkers for Prediction of Epidermal Growth Factor Receptor Mutation in Non-Small Cell Lung Cancer, Transl. Oncol., 11, 94, 10.1016/j.tranon.2017.10.012 Tu, 2019, Radiomics signature: A potential and incremental predictor for EGFR mutation status in NSCLC patients, comparison with CT morphology, Lung cancer (Amsterdam, Netherlands), 132, 28, 10.1016/j.lungcan.2019.03.025 Wang, 2021, Radiomics signature of brain metastasis: prediction of EGFR mutation status, Eur. Radiol., 31, 4538, 10.1007/s00330-020-07614-x Lambin, 2012, Radiomics: Extracting more information from medical images using advanced feature analysis, Eur. J. Cancer, 48, 441, 10.1016/j.ejca.2011.11.036 Song, 2021, Deep learning predicts epidermal growth factor receptor mutation subtypes in lung adenocarcinoma, Med. Phys., 48, 7891, 10.1002/mp.15307 Deng, 2009, ImageNet: a Large-Scale Hierarchical Image Database, IEEE Conference on Computer Vision and Pattern Recognition., 248–255 Lin M, Chen Q, Yan S. Network in network. In: International Conference on Learning Representations (ICLR). 2014. van Griethuysen, J., Fedorov, A., Parmar, C., Hosny, A., Aucoin, N., Narayan, V., Beets-Tan, R., Fillion-Robin, J. C., Pieper, S., & Aerts, H. (2017). Computational Radiomics System to Decode the Radiographic Phenotype. Cancer research, 77(21), e104–e107. https://doi.org/10.1158/0008-5472.CAN-17-0339. Koo, 2016, A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research, J. Chiropractic Med., 15, 155, 10.1016/j.jcm.2016.02.012 Yin, 2019, Comparison of radiomics machine-learning classifiers and feature selection for differentiation of sacral chordoma and sacral giant cell tumour based on 3D computed tomography features, Eur. Radiol., 29, 1841, 10.1007/s00330-018-5730-6 Ruopp, 2008, Youden Index and optimal cut-point estimated from observations affected by a lower limit of detection, Biometr. J. Biometrische Zeitschrift, 50, 419, 10.1002/bimj.200710415 Rs, 2020, Grad-CAM: Visual Explanations from Deep Networks via Gradient-Based Localization, Int. J. Comput. Vision, 128 Tan, Mingxing & Le, Quoc. (2019). EfficientNet: Rethinking Model Scaling for Convolutional Neural Networks. Jiang, 2021, MRI Based Radiomics Approach With Deep Learning for Prediction of Vessel Invasion in Early-Stage Cervical Cancer, IEEE/ACM Trans. Comput. Biol. Bioinf., 18, 995, 10.1109/TCBB.2019.2963867 Li, 2021, 3D IFPN: Improved Feature Pyramid Network for Automatic Segmentation of Gastric Tumor, Front. Oncol., 11 Wang, 2021, Boosted EfficientNet: Detection of Lymph Node Metastases in Breast Cancer Using Convolutional Neural Networks, Cancers, 13, 661, 10.3390/cancers13040661 Zhao, 2019, Toward automatic prediction of EGFR mutation status in pulmonary adenocarcinoma with 3D deep learning, Cancer medicine, 8, 3532, 10.1002/cam4.2233 Qin, 2020, Multi-Type Interdependent Feature Analysis Based on Hybrid Neural Networks for Computer-Aided Diagnosis of Epidermal Growth Factor Receptor Mutations, IEEE Access, 8, 38517, 10.1109/ACCESS.2020.2971281 Guo, 2019, Intratumoral heterogeneity of EGFR-activating mutations in advanced NSCLC patients at the single-cell level, BMC cancer, 19, 369, 10.1186/s12885-019-5555-y